Internal link ProQR to Present Findings from Phase 1/2 Interim Analysis of QR-421a for Usher Syndrome March 25, 2020 at 08:15 PM UTC
Internal link ProQR Announces Fourth Quarter and Full Year 2019 Results and Provides Business Update February 26, 2020 at 12:00 PM UTC
Internal link ProQR to Present at Cowen and Company 40th Annual Health Care Conference February 24, 2020 at 12:00 PM UTC
Internal link ProQR Therapeutics Teams Up with the Foundation Fighting Blindness and Blueprint Genetics to Support the My Retina TrackerĀ® Program for People Living with Inherited Retinal Diseases February 06, 2020 at 12:00 PM UTC
Internal link ProQR Receives Rare Pediatric Disease Designation from FDA for QR-421a January 30, 2020 at 12:00 PM UTC